These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 9172002)

  • 1. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
    Greco A; Miranda C; Pagliardini S; Fusetti L; Bongarzone I; Pierotti MA
    Genes Chromosomes Cancer; 1997 Jun; 19(2):112-23. PubMed ID: 9172002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the NTRK1 genomic region involved in chromosomal rearrangements generating TRK oncogenes.
    Greco A; Mariani C; Miranda C; Pagliardini S; Pierotti MA
    Genomics; 1993 Nov; 18(2):397-400. PubMed ID: 8288244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
    Butti MG; Bongarzone I; Ferraresi G; Mondellini P; Borrello MG; Pierotti MA
    Genomics; 1995 Jul; 28(1):15-24. PubMed ID: 7590742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The DNA rearrangement that generates the TRK-T3 oncogene involves a novel gene on chromosome 3 whose product has a potential coiled-coil domain.
    Greco A; Mariani C; Miranda C; Lupas A; Pagliardini S; Pomati M; Pierotti MA
    Mol Cell Biol; 1995 Nov; 15(11):6118-27. PubMed ID: 7565764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.
    Greco A; Pierotti MA; Bongarzone I; Pagliardini S; Lanzi C; Della Porta G
    Oncogene; 1992 Feb; 7(2):237-42. PubMed ID: 1532241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The trk family of oncogenes and neurotrophin receptors.
    Lamballe F; Klein R; Barbacid M
    Princess Takamatsu Symp; 1991; 22():153-70. PubMed ID: 1844238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncogenic rearrangements of the RET proto-oncogene in papillary thyroid carcinomas from children exposed to the Chernobyl nuclear accident.
    Fugazzola L; Pilotti S; Pinchera A; Vorontsova TV; Mondellini P; Bongarzone I; Greco A; Astakhova L; Butti MG; Demidchik EP
    Cancer Res; 1995 Dec; 55(23):5617-20. PubMed ID: 7585643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Search for NTRK1 proto-oncogene rearrangements in human thyroid tumours originated after therapeutic radiation.
    Bounacer A; Schlumberger M; Wicker R; Du-Villard JA; Caillou B; Sarasin A; Suárez HG
    Br J Cancer; 2000 Jan; 82(2):308-14. PubMed ID: 10646882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proximity of TPR and NTRK1 rearranging loci in human thyrocytes.
    Roccato E; Bressan P; Sabatella G; Rumio C; Vizzotto L; Pierotti MA; Greco A
    Cancer Res; 2005 Apr; 65(7):2572-6. PubMed ID: 15805251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the TFG N-terminus and coiled-coil domain in the transforming activity of the thyroid TRK-T3 oncogene.
    Greco A; Fusetti L; Miranda C; Villa R; Zanotti S; Pagliardini S; Pierotti MA
    Oncogene; 1998 Feb; 16(6):809-16. PubMed ID: 9488046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
    Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
    Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic rearrangements of the NTRK1/NGF receptor.
    Pierotti MA; Greco A
    Cancer Lett; 2006 Jan; 232(1):90-8. PubMed ID: 16242838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
    Greco A; Miranda C; Pierotti MA
    Mol Cell Endocrinol; 2010 May; 321(1):44-9. PubMed ID: 19883730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genomic organization of the human NTRK1 gene.
    Greco A; Villa R; Pierotti MA
    Oncogene; 1996 Dec; 13(11):2463-6. PubMed ID: 8957089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rearrangements of NTRK1 oncogene in papillary thyroid carcinoma.
    Brzeziańska E; Pastuszak-Lewandoska D; Lewiński A
    Neuro Endocrinol Lett; 2007 Jun; 28(3):221-9. PubMed ID: 17627253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of TRK-T1 oncogene induces differentiation of PC12 cells.
    Greco A; Orlandi R; Mariani C; Miranda C; Borrello MG; Cattaneo A; Pagliardini S; Pierotti MA
    Cell Growth Differ; 1993 Jul; 4(7):539-46. PubMed ID: 8398895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncogenic activation of the tyrosine kinase domain of the human trk proto-oncogene by fusion to a cell adhesion molecule.
    Albor A; Thraves PJ; Dritschilo A; Notario V
    Oncogene; 1996 Oct; 13(8):1755-63. PubMed ID: 8895522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping of the tyrosine kinase receptors trkA (NTRK1), trkB (NTRK2) and trkC(NTRK3) to human chromosomes 1q22, 9q22 and 15q25 by fluorescence in situ hybridization.
    Valent A; Danglot G; Bernheim A
    Eur J Hum Genet; 1997; 5(2):102-4. PubMed ID: 9195161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ret/PTC3 is the most frequent form of gene rearrangement in papillary thyroid carcinomas in Japan.
    Kitamura Y; Minobe K; Nakata T; Shimizu K; Tanaka S; Fujimori M; Yokoyama S; Ito K; Onda M; Emi M
    J Hum Genet; 1999; 44(2):96-102. PubMed ID: 10083732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of TFG sequences outside the coiled-coil domain in TRK-T3 oncogenic activation.
    Roccato E; Pagliardini S; Cleris L; Canevari S; Formelli F; Pierotti MA; Greco A
    Oncogene; 2003 Feb; 22(6):807-18. PubMed ID: 12584559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.